Purple Biotech Ltd Working Capital to Net Assets Ratio
Purple Biotech Ltd working capital to net assets ratio. Purple Biotech Ltd (PPBT) has a Working Capital to Net Assets ratio of 14.4% as of September 2025. Working capital of ILA4.72 Million (current assets of ILA10.77 Million minus current liabilities of ILA6.06 Million) is measured against net assets of ILA32.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check PPBT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Purple Biotech Ltd (2017–2024)
Working capital to net assets ratio of Purple Biotech Ltd from 2017 to 2024. This chart shows how Purple Biotech Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 14.4%, reflecting working capital of ILA4.72 Million against net assets of ILA32.81 Million ILA. See PPBT defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Purple Biotech Ltd Working Capital to Net Assets Ratio by Year (2017–2024)
Purple Biotech Ltd working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Purple Biotech Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Purple Biotech Ltd.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 15.0% | ILA4.92 Million | ILA32.91 Million | ILA8.91 Million | ILA3.99 Million | ▼ -2.8 pp |
| 2023 | 17.7% | ILA6.09 Million | ILA34.30 Million | ILA15.79 Million | ILA9.70 Million | ▼ -37.9 pp |
| 2022 | 55.6% | ILA26.20 Million | ILA47.10 Million | ILA33.26 Million | ILA7.06 Million | ▼ -12.3 pp |
| 2021 | 67.9% | ILA44.22 Million | ILA65.11 Million | ILA48.47 Million | ILA4.25 Million | ▼ -2.5 pp |
| 2020 | 70.4% | ILA56.18 Million | ILA79.75 Million | ILA59.28 Million | ILA3.10 Million | ▲ +26.7 pp |
| 2019 | 43.8% | ILA4.76 Million | ILA10.86 Million | ILA8.30 Million | ILA3.55 Million | ▼ -3.5 pp |
| 2018 | 47.3% | ILA5.20 Million | ILA11.00 Million | ILA8.51 Million | ILA3.31 Million | ▲ +0.6 pp |
| 2017 | 46.7% | ILA4.01 Million | ILA8.59 Million | ILA7.98 Million | ILA3.97 Million | — |